期刊文献+

干扰素治疗慢性丙型肝炎对血液系统影响观察

Side Effects on Blood System in IFNa-2b Against Hepatitis C
下载PDF
导出
摘要 目的观察干扰素治疗慢性丙型肝炎对血液系统影响,为临床提供用药参考。方法用KX-21分别测量3 MU,5 MU干扰素治疗丙型肝炎前后白细胞、血红蛋白、血小板的数值。结果治疗前二组患者血液系统WBC、HGB、PLT水平无统计学差异;治疗后二组的WBC、PLT水平有不同程度的减少。结论5 MU与3 MU干扰素在治疗慢性丙型肝炎中均对血液系统产生不良反应,且随剂量的增多而不良反应增加,建议选用3 MU作为治疗的首选。 Objective To investigate the blood changes in chronic hepatitis C patients cured with IFNa- 2b. Metbeds According to the dosage of IFNa- 2b, 42 patients were assigned into two groups, one group was treated with 3MU, and another group with 5MU. SYSMEX KX- 21 was used to detect the patient's white blood cell, hemoglobin and platelet before and after taking the IFNa- 2b therapy. Result Before treating with IFNa - 2b, the levels of WBC, HGB and PLT in these two groups showed no statistical difference, while after the treatment, white blood cell and platelet stepped down differently in a dose - dependant manner. Conclusion The IFNa - 2b therapy shows adverse effects on blood system in a dose - dependant manner, and the 3MU regimen might be the first choice in the treatment.
出处 《实用预防医学》 CAS 2007年第2期301-302,共2页 Practical Preventive Medicine
基金 深圳市福田区科技局(FT200627)
关键词 丙型肝炎 干扰素A-2B 不良反应 血液系统 Hepatitis C Interferon Alfa - 2b Side effect
  • 相关文献

参考文献6

二级参考文献38

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2徐道振,谢尧,陆志檬,骆抗先,贾继东,王宇明,赵桂珍,张树林,张大志.聚乙二醇干扰素α-2a与干扰素α-2a治疗慢性丙型肝炎疗效、安全性的评估[J].中华传染病杂志,2004,22(4):221-224. 被引量:37
  • 3Fontana RJ. Uric acid nephrolithiasis associated with interferon and ribavirin treatment of hepatitis C. Dig Dis Sci, 2001, 46 (4) : 920-924.
  • 4Adinolfi LE, Durante Mangoni E, Androana A. Interferon and ribavifin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol, 2001, 96 (2): 607-608.
  • 5Lavanchy D. Hepatitis B virus epidemiology, disease hurden, treatment,and current and emerging prevention and control measures. J Viral Hepat,2004, 11 (2): 97-107.
  • 6Ganem D. Prince AM. Hepatitis B virus infection-natural history andclinical consequences. N Engl J Med, 2004, 350 (11 ) : 1118-1129.
  • 7Camma C, Di Bona D, Schepis F, et al. Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C : a meta-analysis of individual patient data. Hepatology, 2004, 39 (2): 333-342.
  • 8Schulte-Frohlinde E, Seidler B, Burkard I, et al. Different activities oftype I interferons on hepatitis B virus core promoter regulated transcription. Cytokine, 2002, 17 (4): 214-220.
  • 9Moskovitz DN, Manoharan P, Heathcote EJ. High dose consensus interferon in nonresponders to interferon alpha-2h and ribavirin with chronic hepatitis C. Can J Gastroenterol, 2003, 17 (8) : 479-482.
  • 10Kaito M, Yasui-Kawamura N, Iwasa M, et al. Twice-a-day versus oncea-day interferon-beta therapy in chronic hepatitis C. Hepatogastroenterology, 2003, 50 (3): 775-778.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部